Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Pacific Biosciences of California Inc. sell StockNews.com

Start price
€1.78
15.02.25 / 50%
Target price
-
15.02.26
Performance (%)
-16.80%
End price
€1.48
16.02.26
Summary
This prediction ended on 16.02.26 with a price of €1.48. The prediction for Pacific Biosciences of California Inc. closed with a convincing performance of -16.80%. StockNews_com has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Pacific Biosciences of California Inc. -16.926% -16.926% -2.066%
iShares Core DAX® -6.016% -4.595% 1.274%
iShares Nasdaq 100 0.511% 0.164% 14.573%
iShares Nikkei 225® -7.156% -2.215% 28.107%
iShares S&P 500 -0.257% -0.841% 10.196%

Comments by StockNews_com for this prediction

In the thread Pacific Biosciences of California Inc. diskutieren

Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for PACB provided by MarketBeat

In the thread Trading Pacific Biosciences of California Inc.
Prediction Sell
Perf. (%) -16.80%
Target price
Change
Ends at 15.02.26

Die von StockNews_com gewählte maximale Laufzeit wurde überschritten

Stopped prediction by StockNews_com for Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€1.39
18.04.24
-
18.04.25
-27.05%
19.04.25

Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€3.86
12.03.24
-
12.03.25
-69.22%
13.03.25

Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€5.85
13.01.24
-
13.01.25
-65.82%
14.01.25

Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€9.37
29.12.23
-
29.12.24
-80.02%
30.12.24